Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study
Schettini, Francesco, Saracchini, Silvana, Bassini, Anna, Marus, Wally, Corsetti, Serena, Specogna, Ilaria, Bertola, Manuela, Micheli, Elvia, Wirtz, Ralph M., Laible, Mark, Şahin, Uğur, Strina, Carla, Milani, Manuela, Aguggini, Sergio, Tancredi, Richard, Fiorio, Elena, Sulfaro, Sandro, Generali, Daniele
Published in Breast (Edinburgh) (01.08.2024)
Published in Breast (Edinburgh) (01.08.2024)
Get full text
Journal Article
Seven fractions to deliver partial breast irradiation: the toxicity is Low
Trovo, Marco, Avanzo, Michele, Vinante, Lorenzo, Furlan, Carlo, Fiorica, Francesco, Perin, Tiziana, Militello, Loredana, Spazzapan, Simon, Berretta, Massimiliano, Jena, Rajesh, Stancanello, Joseph, Piccoli, Erica, Mileto, Mario, Micheli, Elvia, Roncadin, Mario, Massarut, Samuele
Published in Radiation oncology (London, England) (23.05.2017)
Published in Radiation oncology (London, England) (23.05.2017)
Get full text
Journal Article
Abstract P1-10-23: Prediction of pathological complete response (pCR) upon neoadjuvant chemotherapy by MammaTyper® pCR score
Saracchini, Silvana, Bassini, Anna, Marus, Wally, Corsetti, Serena, Specogna, Ilaria, Bertola, Manuela, Micheli, Elvia, Wirtz, Ralph M, Laible, Mark, Sahin, Ugur, Generali, Daniele, Sulfaro, Sandro
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Ten daily fractions for partial breast irradiation. Long‐term results of a prospective phase II trial
Vinante, Lorenzo, Avanzo, Michele, Furlan, Carlo, Fiorica, Francesco, Perin, Tiziana, Militello, Loredana, Spazzapan, Simon, Berretta, Massimiliano, Jena, Rajesh, Stancanello, Joseph, Piccoli, Erica, Mileto, Mario, Micheli, Elvia, Roncadin, Mario, Massarut, Samuele, Trovò, Marco
Published in The breast journal (01.03.2019)
Published in The breast journal (01.03.2019)
Get full text
Journal Article
Neoadjuvant chemotherapy with nonpegylated liposome-encapsulated doxorubicin (NPLD) plus cyclophosphamide followed by trastuzumab plus nabpaclitaxel for HER2-positive breast cancer (BC)
Saracchini, Silvana, Foltran, Luisa, Bassini, Anna, Sulfaro, Sandro, Lorenzon, Michele, Micheli, Elvia, Favero, Alessandro, Marus, Wally, Del Conte, Alessandro, Gusso, Giuseppina, Manente, Stefania, Tumolo, Salvatore
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Liposome-encapsulated doxorubicin plus cyclophosphamide followed by trastuzumab plus docetaxel as neoadjuvant therapy for HER2-positive breast cancer (BC): A multicenter single-arm phase II study
Saracchini, Silvana, Foltran, Luisa, Sulfaro, Sandro, Tuccia, Fausto, Del Conte, Alessandro, Bertola, Manuela, Bassini, Anna, Micheli, Elvia, Manente, Stefania, Gusso, Giuseppina, Baresic, Tania, Tumolo, Salvatore
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Toxicity and cosmesis following partial breast irradiation consisting of 40 Gy in 10 daily fractions
Trovo, Marco, Roncadin, Mario, Polesel, Jerry, Piccoli, Erica, Mileto, Mario, Micheli, Elvia, Perin, Tiziana, Carbone, Antonino, Massarut, Samuele, Trovo, Mauro G
Published in Breast (Edinburgh) (01.10.2013)
Published in Breast (Edinburgh) (01.10.2013)
Get full text
Journal Article